NCT00842504View on ClinicalTrials.gov

Alternate Day Micafungin: A PK Study in Pediatric Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Fungal Infection

Interventions

DRUG

Micafungin

3 mg/kg IV once over 1 hour

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER